Skip to main content
Fig. 5 | Journal of Ovarian Research

Fig. 5

From: NCAPH promotes glucose metabolism reprogramming and cell stemness in ovarian cancer cells through the MEK/ERK/PD-L1 pathway

Fig. 5

NCAPH silencing suppressed the stemness of ovarian cancer cells via the inhibition of MEK/ERK/PD-L1 signaling pathway. A Cell stemness was assessed using a spheroid formation assay. B The expression levels of stem cell markers were evaluated using Western blot analysis. All experiments were performed in triplicate.*P < 0.05, **P < 0.01 and ***P < 0.001

Back to article page